Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Eating Behaviour in Obesity
NCT06189001Completed
- Sponsor
- Gentofte Hospital
- Start
- Jan 2024
- Primary completion
- Sep 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity comparing Oxytocin First with Placebo First (2 arms). Primary endpoint: Ad libitum food intake. Started Jan 2024; status: completed.
02
Drugs
oxytocin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06189001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06189001.